IMMUNOHISTOCHEMICAL DETECTION OF BCL-2 PROTEIN IN NORMAL AND PATHOLOGICAL HUMAN LIVER

Citation
F. Charlotte et al., IMMUNOHISTOCHEMICAL DETECTION OF BCL-2 PROTEIN IN NORMAL AND PATHOLOGICAL HUMAN LIVER, The American journal of pathology, 144(3), 1994, pp. 460-465
Citations number
26
Categorie Soggetti
Pathology
ISSN journal
00029440
Volume
144
Issue
3
Year of publication
1994
Pages
460 - 465
Database
ISI
SICI code
0002-9440(1994)144:3<460:IDOBPI>2.0.ZU;2-L
Abstract
The bcl-2 protein, which prolongs cell survival by blocking apoptosis, is expressed by progenitor cells in several self-renewing tissues and by tumoral cells in some extrahepatic neoplasms. Because the liver is a slow self-renewing tissue, an immunohistochemical study of the cell ular distribution of the bcl-2 protein was performed in normal liver ( 12 cases), nontumoral hepatic lesions (33 cases), and benign or malign ant liver tumors (46 cases). In normal liver, bcl-2 was expressed by b ile ductules and small bile duct epithelium, but not by hepatocytes or large bile duct epithelium. lit cirrhosis and focal nodular hyperplas ia, epithelial cells of the ductular proliferation were bcl-2-positive . Eight of II cholangiocarcinomas stained positively for bcl-2, wherea s all 15 hepatocellular carcinomas were bcl-2-negative. bcl-2 was also expressed in 6 of 14 metastatic adenocarcinomas. These findings sugge st that the ductular cells and small bile duct epithelial cells might have a prolonged survival and might be hepatic progenitor cells. In ad dition, the bcl-2-protein appears to be a marker of cholangiocarcinoma but not of hepatocellular carcinoma and could help in distinguishing between these two primary liver tumors.